FACTORS RELATED TO THE RESULTS OF ENDOVASCULAR INTERVENTION IN THE TREATMENT OF CHRONIC FEMORAL-POLITEAL ARTERY OCCLUSION TASC C AND D IN THE ELDERLY

Luân Trần Minh Bảo, Tân Nguyễn Duy, Quân Đào Hồng

Main Article Content

Abstract

Objectives: Evaluating the results of endovascular intervention in the treatment of stenosis/occlusion of the femoral-popliteal artery TASC C, D in elderly patients. Methods: Retrospective- case series deciptive study conducted at Cardiovascular and Thoracic Surgery Department, Thong Nhat Hospital. Ho Chi Minh city. Results: From June 2020 to June 2024, there were 83 cases of stenosis/occlusion of the femoral-popliteal artery TASC C, D; Average age 77.4 ± 7.4 years (65-99); 64 males (77.1%) and 19 females (22.9%); vascular lesions TASC C (43.4%), TASC D (56.6%), mean ABI was 0.5 ± 0.2. Technical success 97.5% (balloon angioplasty 3.6%, balloon angioplasty + stent 93.9%), failure 2.4%. Average intervention time 118 ± 17.3 minutes (90.5 – 135); Complications: hematoma in 9 cases (10.8%), 1 case of balloon rupture during dilation. The average post-intervention ABI was 0.8 ± 0.2. The results of endovascular intervention depend on factors: the older age and the more severe level of vascular damage, the lower success rate and the longer intervention duration (p<0.05). Conclusion: Endovascular intervention in treatment of stenosis/occlusion of stenosis/occlusion of the femoral-popliteal artery TASC C, D, especially for the elderly has a high technical success rate, the older age and the more severe level of vascular damage, the lower success rate and the longer intervention duration.

Article Details

References

1. American Heart Association (AHA). 2016 Heart Disease and Stroke Statistics. Circulation. 2016;133. doi:10.1161/CIR.0000000000000350.
2. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision-making. J Vasc Surg. 2010;51(5 Suppl):52S-68S.
3. Baker C, Wong D. The Wong-Baker FACES pain rating scale. Pediatric Nursing. 1987;14(1):9-17.
4. Giannopoulos S, Armstrong EJ. Risk factors and outcomes of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2020;59(4):512-518. doi:10.1016/j.ejvs.2019.12.024.
5. Rammos C, Sianis A, Werner C, et al. Coronary artery disease in peripheral arterial disease. J Vasc Surg. 2024;70(3):1234-1242. doi:10.1016/j.jvs.2024.01.045.
6. Zeller T, Rastan A, Macharzina R, Pilger E. Endovascular therapy of chronic femoral artery occlusions. J Cardiovasc Surg. 2011;52(3):357-366.
7. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision-making. J Vasc Surg. 2010;51(5 Suppl):52S-68S.
8. Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Eur J Vasc Endovasc Surg. 2015;49(4):519-529. doi:10.1016/j.ejvs.2015.01.019.
9. Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879-1888. doi:10.1056/ NEJMoa051303.
10. Liu Z, Chen X, Wang Y, et al. Endovascular therapy for TASC II C and D femoropopliteal occlusive disease: outcomes and predictors of patency. J Vasc Surg. 2023;78(4):987-994. doi:10.1016/j.jvs.2023.03.015.